CLDHF(CLDHF)
CLDHF
No analyst ratings available
No analyst price targets available for CLDHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $214M | $219M | $204M |
| Low | $213M | $217M | $202M |
| High | $214M | $220M | $205M |
| EBITDA Avg | $119M | $122M | $113M |
| Low | $119M | $121M | $113M |
| High | $119M | $123M | $114M |
| EBIT Avg | $118M | $121M | $113M |
| Low | $118M | $120M | $112M |
| High | $119M | $122M | $113M |
| Net Income Avg | $52M | $54M | $44M |
| Low | $51M | $53M | $43M |
| High | $52M | $54M | $44M |
| EPS Avg | $0.04 | $0.04 | $0.03 |
| Low | $0.04 | $0.04 | $0.03 |
| High | $0.04 | $0.04 | $0.03 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $149M | $149M | $149M |
| Low | $149M | $149M | $149M |
| High | $149M | $149M | $149M |
| EBITDA Avg | $83M | $83M | $83M |
| Low | $83M | $83M | $83M |
| High | $83M | $83M | $83M |
| EBIT Avg | $82M | $82M | $82M |
| Low | $82M | $82M | $82M |
| High | $82M | $82M | $82M |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — |